TY - JOUR
T1 - Assessing Health-Related Quality of Life in Children and Adolescents with Diabetes
T2 - Development and Psychometrics of the Type 1 Diabetes and Life (T1DAL) Measures
AU - Hilliard, Marisa E.
AU - Minard, Charles G.
AU - Marrero, David G.
AU - De Wit, Maartje
AU - Thompson, Debbe
AU - Dubose, Stephanie N.
AU - Verdejo, Alandra
AU - Monzavi, Roshanak
AU - Wadwa, R. Paul
AU - Jaser, Sarah S.
AU - Anderson, Barbara J.
N1 - Funding Information:
Research funding for this study came from the Leona M. and Harry B. Helmsley Charitable Trust (2015PG-T1D084, PIs: Anderson and Hilliard). Drs. Hilliard and Anderson also received complementary support from the National Institutes of Health (1K12DK097696, PI: Anderson). The study team wishes to thank research staff and collaborators for this study: Viena Cao, Sahar Eshtehardi, Brett McKinney, Sharyl Wee, Jaquelin Flores Garcia, Emily Hamburger, Tyler Reznikck-Lipina, Kimberly Savin, and Georgeanna Klingensmith MD. Additional thanks to the Site PIs for the adult T1DAL measures (reported elsewhere): Davida Kruger MSN APN-BC BC-ADM, Ruth Weinstock MD PhD, and Viral Shah MD.
Publisher Copyright:
© 2019 The Author(s) 2019. Published by Oxford University Press on behalf of the Society of Pediatric Psychology. All rights reserved.
PY - 2020/4/1
Y1 - 2020/4/1
N2 - Objective: To develop and validate new measures of diabetes-specific health-related quality of life (HRQOL) for people with type 1 diabetes (T1D) that are brief, developmentally appropriate, and usable in clinical research and care. Here we report on the phases of developing and validating the self-report Type 1 Diabetes and Life (T1DAL) measures for children (age 8-11) and adolescents (age 12-17). Methods: Measure development included qualitative interviews with youth and parents (n = 16 dyads) followed by piloting draft measures and conducting cognitive debriefing with youth (n = 9) to refine the measures. To evaluate the psychometric properties, children (n = 194) and adolescents (n = 257) at three T1D Exchange Clinic Network sites completed the age-appropriate T1DAL measure and previously validated questionnaires measuring related constructs. Using psychometric data, the investigators reduced the length of each T1DAL measure to 21 and 23 items, respectively, and conducted a final round of cognitive debriefing with six children and adolescents. Results: The T1DAL measures for children and adolescents demonstrated good internal consistency (α = 0.84 and 0.89, respectively) and test-retest reliability (r = 0.78 and 0.80, respectively). Significant correlations between the T1DAL scores and measures of general quality of life, generic and diabetes-specific HRQOL, diabetes burden, and diabetes strengths demonstrated construct validity. Correlations with measures of self-management (child and adolescent) and glycemic control (adolescent only) demonstrated criterion validity. Factor analyses indicated four developmentally specific subscales per measure. Participants reported satisfaction with the measures. Conclusions: The new T1DAL measures for children and adolescents with T1D are reliable, valid, and suitable for use in care settings and clinical research.
AB - Objective: To develop and validate new measures of diabetes-specific health-related quality of life (HRQOL) for people with type 1 diabetes (T1D) that are brief, developmentally appropriate, and usable in clinical research and care. Here we report on the phases of developing and validating the self-report Type 1 Diabetes and Life (T1DAL) measures for children (age 8-11) and adolescents (age 12-17). Methods: Measure development included qualitative interviews with youth and parents (n = 16 dyads) followed by piloting draft measures and conducting cognitive debriefing with youth (n = 9) to refine the measures. To evaluate the psychometric properties, children (n = 194) and adolescents (n = 257) at three T1D Exchange Clinic Network sites completed the age-appropriate T1DAL measure and previously validated questionnaires measuring related constructs. Using psychometric data, the investigators reduced the length of each T1DAL measure to 21 and 23 items, respectively, and conducted a final round of cognitive debriefing with six children and adolescents. Results: The T1DAL measures for children and adolescents demonstrated good internal consistency (α = 0.84 and 0.89, respectively) and test-retest reliability (r = 0.78 and 0.80, respectively). Significant correlations between the T1DAL scores and measures of general quality of life, generic and diabetes-specific HRQOL, diabetes burden, and diabetes strengths demonstrated construct validity. Correlations with measures of self-management (child and adolescent) and glycemic control (adolescent only) demonstrated criterion validity. Factor analyses indicated four developmentally specific subscales per measure. Participants reported satisfaction with the measures. Conclusions: The new T1DAL measures for children and adolescents with T1D are reliable, valid, and suitable for use in care settings and clinical research.
KW - developmental perspectives
KW - diabetes
KW - quality of life
UR - http://www.scopus.com/inward/record.url?scp=85082144752&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85082144752&partnerID=8YFLogxK
U2 - 10.1093/jpepsy/jsz083
DO - 10.1093/jpepsy/jsz083
M3 - Article
C2 - 31665389
AN - SCOPUS:85082144752
SN - 0146-8693
VL - 45
SP - 328
EP - 339
JO - Journal of Pediatric Psychology
JF - Journal of Pediatric Psychology
IS - 3
ER -